Finance

Lists
688506:SHA
Sichuan Biokin Pharmaceutical Co Ltd
233,88 CN¥
+1,17%
(+2,71) 1D
16 қаз., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688506...
Open
233,33 CN¥
High
242,99 CN¥
Low
230,10 CN¥
Mkt. cap
96,56 млрд
Avg. vol.
1,57 млн
Volume
1,83 млн
52-wk high
404,00 CN¥
52-wk low
200,10 CN¥
EPS
-3,79 CN¥
No. of employees
3 мың
Open
233,33 CN¥
High
242,99 CN¥
Low
230,10 CN¥
Mkt. cap
96,56 млрд
Avg. vol.
1,57 млн
Volume
1,83 млн
52-wk high
404,00 CN¥
52-wk low
200,10 CN¥
EPS
-3,79 CN¥
No. of employees
3 мың
News stories
From web sources and news partners
Profile
Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia
About Sichuan Biokin Pharmaceutical Co Ltd
CEO-
Employees3,43 мың
Founded1996 ж. 23 там.
Headquarters-
SectorPharmaceutical industry
Websiteen.baili-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,89 млрд
454,22 млн
94,59 млн
92,75 млн
Cost of goods sold
43,74 млн
115,66 млн
43,37 млн
59,34 млн
Cost of revenue
43,74 млн
115,66 млн
43,37 млн
59,34 млн
Research and development expenses
733,75 млн
741,34 млн
694,76 млн
787,93 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144,15 млн
169,94 млн
126,35 млн
113,01 млн
Operating expense
862,71 млн
926,05 млн
813,01 млн
892,42 млн
Total operating expenses
906,45 млн
1,04 млрд
856,38 млн
951,76 млн
Operating income
988,25 млн
-587,49 млн
-761,79 млн
-859,01 млн
Other non operating income
-68,11 млн
68,05 млн
-142,74 млн
142,75 млн
EBT including unusual items
942,32 млн
-535,84 млн
-776,15 млн
-901,42 млн
EBT excluding unusual items
977,50 млн
-586,93 млн
-841,61 млн
-965,12 млн
Income tax expense
318,88 млн
23,26 млн
-1,59 млн
-38,76 млн
Effective tax rate
33,84%
-4,34%
0,21%
4,30%
Other operating expenses
-15,12 млн
14,55 млн
-7,43 млн
-9,01 млн
Net income
623,44 млн
-559,10 млн
-774,56 млн
-862,66 млн
Net profit margin
32,90%
-123,09%
-818,89%
-930,11%
Earnings per share
-
-
-
-
Interest and investment income
54,03 млн
56,43 млн
89,48 млн
36,67 млн
Interest expense
-24,43 млн
-26,18 млн
-26,56 млн
-29,06 млн
Net interest expenses
29,60 млн
30,26 млн
62,92 млн
7,62 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,01 млрд
-567,21 млн
-741,51 млн
-836,43 млн
Gain or loss from assets sale
1,06 мың
-1,06 мың
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары